Critical Modulation of Hematopoietic Lineage Fate by Hepatic Leukemia Factor

Cell Rep. 2017 Nov 21;21(8):2251-2263. doi: 10.1016/j.celrep.2017.10.112.

Abstract

A gradual restriction in lineage potential of multipotent stem/progenitor cells is a hallmark of adult hematopoiesis, but the underlying molecular events governing these processes remain incompletely understood. Here, we identified robust expression of the leukemia-associated transcription factor hepatic leukemia factor (Hlf) in normal multipotent hematopoietic progenitors, which was rapidly downregulated upon differentiation. Interference with its normal downregulation revealed Hlf as a strong negative regulator of lymphoid development, while remaining compatible with myeloid fates. Reciprocally, we observed rapid lymphoid commitment upon reduced Hlf activity. The arising phenotypes resulted from Hlf binding to active enhancers of myeloid-competent cells, transcriptional induction of myeloid, and ablation of lymphoid gene programs, with Hlf induction of nuclear factor I C (Nfic) as a functionally relevant target gene. Thereby, our studies establish Hlf as a key regulator of the earliest lineage-commitment events at the transition from multipotency to lineage-restricted progeny, with implications for both normal and malignant hematopoiesis.

Keywords: gene regulation; hematopoiesis; lineage commitment; lymphopoiesis; myelopoiesis; transcription factor.

MeSH terms

  • Animals
  • Basic-Leucine Zipper Transcription Factors / metabolism
  • Cell Differentiation / physiology
  • Cell Lineage / physiology*
  • Gene Expression Regulation / physiology
  • Hematopoiesis / genetics*
  • Hematopoietic Stem Cells / cytology*
  • Leukemia / metabolism*
  • Lymphopoiesis / physiology
  • Mice
  • Multipotent Stem Cells / cytology*
  • Myeloid Cells / metabolism

Substances

  • Basic-Leucine Zipper Transcription Factors
  • HLF protein, human